Abstract
Since the earliest reports of the Coronavirus disease - 2019 (COVID-19) in Wuhan, China in December 2019, the disease has rapidly spread worldwide, attaining pandemic levels in early March 2020. However, the spread of COVID-19 has differed in the African setting compared to countries on other continents. To predict the spread of COVID-19 in Africa and within each country on the continent, we applied a Susceptible-Infectious-Recovered mathematical model. Here, our results show that, overall, Africa is currently (July 24, 2020) at the peak of the COVID-19 pandemic, after which we predict the number of cases would begin to fall in August 2020. Furthermore, we predict that the ending phase of the pandemic would be in Late-November 2020 and that decreasing cases of COVID-19 infections would be detected until around August 2021 and September 2021. Our results also reveal that of the 51 countries with reported COVID-19 cases, only eight, including Algeria, Morocco and Zambia, are likely to report higher monthly COVID-19 cases in the coming months of 2020 than those reported in the previous months. Overall, at the end of this pandemic, we predict that approximately 2,201,849 (about 1,451,567 future cases) individuals in Africa would have been infected with the COVID-19 virus. Here, our predictions are data-driven and based on the previously observed trends in the spread of the COVID-19 pandemic. Shifts in the population dynamics and/or changes in the infectiousness of the COVID-19 virus may require new forecasts of the disease spread.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Not Applicable
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
None
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Edited figure 3. Edited the discussion.
Data Availability
The data that support the findings of this study are available at covid.ourworldindata.org.
